Global Indices 10-Nov Prev_Day Abs. Change
Russell 3000 1,789 1,811 -23 -1.26
Nasdaq 11,554 11,714 -160 -1.37
FTSE 6,297 6,186 111 1.79
Nikkei 24,906 24,840 66 0.26
Hang Seng 26,301 26,016 285 1.10
Indian Indices 10-Nov Prev_Day Abs. Change
S&P BSE Sensex 43,278 42,597 680 1.60
Nifty 50 12,631 12,461 170 1.36
Nifty 100 12,683 12,545 138 1.10
Nifty 500 10,269 10,176 93 0.91
Nifty Bank 28,606 27,534 1,072 3.89
S&P BSE Power 1,818 1,814 4 0.21
S&P BSE Small Cap 15,232 15,305 -73 -0.48
S&P BSE HC 18,926 19,634 -709 -3.61
Date P/E Div. Yield P/E Div. Yield
10-Nov 30.43 0.94 34.18 1.26
Month Ago 29.77 0.96 34.71 1.33
Year Ago 27.59 1.15 27.51 1.25
Nifty 50 Top 3 Gainers
Company 10-Nov Prev_Day
Bajaj Finance 4209 3865 8.89
IndusInd Bank 835 775 7.71
L&T Ltd. 1034 966 7.02
Nifty 50 Top 3 Losers Domestic News
Company 10-Nov Prev_Day
Cipla 717 763 -6.01
Tech Mahindra 821 873 -5.90
HCL Tech 810 855 -5.30
Advance Decline Ratio
Advances 1208 827
Declines 1512 1053
Unchanged 171 136
Institutional Flows (Equity)
FII Flows* 63761
MF Flows** 3234
Nov 2020; **2
YoY(%) Current Year Ago
Data as on 09 Nov, 2020
Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
11 November 2020
Since May-17, MOSPI has revised base year of IIP & WPI from 2004-05 to 2011-12, and for CPI from
2010 to 2012
Indian Equity Market
P/E Dividend Yield
• Indian equity markets touched fresh record highs, led by hopes of faster
global economic recovery. Investor sentiments were buoyed after one of
the major global pharma companies confirmed that its vaccine, being jointly
developed with another global pharma major, was 90% effective in
preventing COVID-19 infections.
• Key benchmark indices S&P BSE Sensex and Nifty 50 gained 1.6% and 1.36%
to close at 43,277.65 and 12,631.10 respectively.
• The overall market breadth on BSE was weak with 1,208 scrips advancing
and 1,512 scrips declining. A total of 171 scrips remained unchanged.
• On the BSE sectoral front, S&P BSE Finance was the major gainer, up 3.93%
followed by S&P BSE Bankex, up 3.67% and S&P BSE Capital Goods, up
3.04%. S&P BSE IT was the major loser, down 3.71% followed by S&P BSE
Healthcare, down 3.61% and S&P BSE Teck, down 3.27%.
• In line with the interim recommendations of the 15th finance commission,
the central government has disbursed Rs 6,195.08 crore to 14 states on
account of the eighth equated monthly instalment of the post-devolution
revenue deficit grant. The 14 states are Andhra Pradesh, Assam, Himachal
Pradesh, Kerala, Manipur, Meghalaya, Mizoram, Nagaland, Punjab, Sikkim,
Tamil Nadu, Tripura, Uttarakhand and West Bengal.
• According to ICRA rating agency, Indian states could lower capital outlay on
infrastructure by 10-40% in FY2021 in case of additional expenditure
towards healthcare and public welfare amid COVID-19 pandemic. ICRA said
states account for 37 to 40% of the total infrastructure capital expenditure.
• According to media reports, India’s exports rose 22.47% YoY to $6.75
billion in the first week (1- 7) of Nov 2020, mainly led by strong growth in
pharmaceuticals, gems and jewellery and engineering sectors, which
indicates signs of improvement. Imports went up 13.64% YoY to $9.30
billion. Barring petroleum, imports surged 23.37%. As a result, trade deficit
during the week stood at $2.55 billion.
• Under the Export of Milk and Milk Products (Quality Control, Inspection and
Monitoring) Rules, 2020, government made a health certification
mandatory for all milk and milk product exports. Products will be subject to
stringent quality control, inspection and monitoring. Milk and milk products
not complying with the standards will be prohibited.
• GAIL (India)’s consolidated net profit fell 8.5% at Rs. 1,068.16 crore for the
quarter ended Sep 2020, as against Rs. 1,167.58 crore during the same
quarter last year. The company's revenue from operations fell 24.3% to Rs
13,809.86 crore during the quarter ended Sep 2020 from Rs 18,249.90
crore a year before.
• Adobe said it would buy Workfront for $1.5 billion, a leading job tracking
tool for marketers. The acquisition of Workfront would offer quality,
collaboration, and productivity benefits to marketing teams with siloed
work management solutions that are currently challenged.
• Asian markets edged higher, led by positive developments on the
coronavirus vaccine front. According to media reports, one of the U.S. drug
makers and its German partner announced positive results from their
coronavirus vaccine trial. The news boosted hopes of a swifter global
economic recovery. Today (as on Nov 11), markets are largely trading higher
as investor sentiment are buoyed by a recent positive development on the
coronavirus vaccine front. While Nikkei is up 1.11%, Hang Seng is down
0.28% (as at 8:00 AM IST).
• European markets extended gains amid continued optimism about
coronavirus vaccine even as new cases of infections increased in several
parts across the continent.
• U.S. markets witnessed a mixed trend as the positive impact of the
developments on the coronavirus vaccine front was neutralised by pullback
seen in tech stocks.